Clinical Trials Directory

Trials / Sponsors / Inmune Bio, Inc.

Inmune Bio, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of INKmune in Patients With mCRPC (CaRe Prostate)
Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC
Phase 1 / Phase 22023-11-30
WithdrawnStudy to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflamm
Mild Cognitive Impairment (MCI), Alzheimer Disease, Dementia
Phase 22023-06-01
TerminatedAn Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Alzheimer Disease, Dementia, Brain Diseases
Phase 22023-02-21
CompletedA Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Alzheimer Disease, Dementia, Brain Diseases
Phase 22022-02-28
TerminatedINB03 for the Treatment of Pulmonary Complications From COVID-19
COVID-19
Phase 2 / Phase 32020-10-21
TerminatedA Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
Cancer, MDS-EB, Myelodysplastic Syndromes
Phase 12020-06-15
CompletedA Biomarker-directed Study of XPro1595 in Patients With Alzheimer's
Alzheimer Disease
Phase 12019-11-20